Day

October 27, 2023
27
Oct

Pretargeted radioimmunotherapy shows early promise in treating aggressive ovarian cancer

A recently developed pretargeted radioimmunotherapy (PRIT) system has displayed potential in treating advanced epithelial ovarian cancer with limited side effects. This therapy, known as anti-HER2 225Ac-PRIT, specifically targets a protein commonly found

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.